These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9314917)

  • 1. Serum lipids, lipoprotein lp(a), and plasminogen activator inhibitor-1 in patients with Turner's syndrome before and during growth hormone and estrogen therapy.
    Lanes R; Gunczler P; Palacios A; Villaroel O
    Fertil Steril; 1997 Sep; 68(3):473-7. PubMed ID: 9314917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lp(a) and lipids in adult Turner's syndrome: impact of treatment with 17beta-estradiol and norethisterone.
    Gravholt CH; Christian Klausen I; Weeke J; Sandahl Christiansen J
    Atherosclerosis; 2000 May; 150(1):201-8. PubMed ID: 10781652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term treatment with growth hormone has no persisting effect on lipoprotein(a) in patients with Turner's syndrome.
    Querfeld U; Döpper S; Gradehand A; Kiencke P; Wahn F; Zeisel HJ
    J Clin Endocrinol Metab; 1999 Mar; 84(3):967-70. PubMed ID: 10084580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of recombinant human GH replacement therapy on lipoprotein(a) and other lipid parameters in adults with acquired GH deficiency: results of a double-blind and placebo-controlled trial.
    Nolte W; Rädisch C; Armstrong VW; Hüfner M; von zur Mühlen A
    Eur J Endocrinol; 1997 Nov; 137(5):459-66. PubMed ID: 9405024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of hormonal replacement therapy on lipid and haemostatic factors in post-menopausal ESRD patients.
    Park JS; Jung HH; Yang WS; Kim SB; Min WK; Chi HS
    Nephrol Dial Transplant; 2000 Nov; 15(11):1835-40. PubMed ID: 11071974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose turnover and insulin clearance after growth hormone treatment in girls with Turner's syndrome.
    Monti LD; Brambilla P; Caumo A; Magni F; Omati S; Nizzoli G; di Natale B; Galli-Kienle M; Cobelli C; Chiumello G; Pozza G
    Metabolism; 1997 Dec; 46(12):1482-8. PubMed ID: 9439548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lipoprotein a (Lp(a)) in patients with Turner's syndrome].
    Wikiera B; Bieniasz J; Barg E; Głab E; Noczyńska A
    Pediatr Endocrinol Diabetes Metab; 2010; 16(1):29-32. PubMed ID: 20529603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of medrogestone on plasma lipids and lipoproteins in postmenopausal women using conjugated estrogens: an open randomized comparative study.
    Gevers Leuven JA; van der Mooren MJ; Buytenhek R
    Fertil Steril; 1995 Sep; 64(3):525-31. PubMed ID: 7641905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased sensitivity to insulin-like growth factor I in Turner's syndrome: a study of monocytes and T lymphocytes.
    Hochberg Z; Aviram M; Rubin D; Pollack S
    Eur J Clin Invest; 1997 Jul; 27(7):543-7. PubMed ID: 9263738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testosterone-estradiol-binding globulin in patients with Turner's syndrome: effects of estrogens and acute growth hormone administration.
    Bergink EW; Wolf DL; Wittliff JL; Bruining GJ; Bryson MF; Forbes GB
    J Clin Endocrinol Metab; 1976 Jun; 42(6):1018-23. PubMed ID: 180042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose metabolism, lipid metabolism, and cardiovascular risk factors in adult Turner's syndrome. The impact of sex hormone replacement.
    Gravholt CH; Naeraa RW; Nyholm B; Gerdes LU; Christiansen E; Schmitz O; Christiansen JS
    Diabetes Care; 1998 Jul; 21(7):1062-70. PubMed ID: 9653596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of hormone replacement therapy on lipoprotein(a) and lipid levels in postmenopausal women. Influence of various progestogens and duration of therapy.
    Kim CJ; Min YK; Ryu WS; Kwak JW; Ryoo UH
    Arch Intern Med; 1996 Aug 12-26; 156(15):1693-700. PubMed ID: 8694668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of acute high dose and chronic low dose estrogen on plasma somatomedin-C and growth in patients with Turner's syndrome.
    Copeland KC
    J Clin Endocrinol Metab; 1988 Jun; 66(6):1278-82. PubMed ID: 3372687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac mass and function, carotid artery intima-media thickness, and lipoprotein levels in growth hormone-deficient adolescents.
    Lanes R; Gunczler P; Lopez E; Esaa S; Villaroel O; Revel-Chion R
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1061-5. PubMed ID: 11238486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
    Zegura B; Guzic-Salobir B; Sebestjen M; Keber I
    Menopause; 2006; 13(4):643-50. PubMed ID: 16837886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperlipidemia and presence of thyroid autoantibodies in girls with Turner's syndrome or mosaic variance.
    Mitsibounas DN; Kosmaidou Z; Kontoleon P; Deligeoroglou E; Liberatou E
    J Pediatr Adolesc Gynecol; 1997 Aug; 10(3):133-9. PubMed ID: 9288657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Body composition and physical fitness are major determinants of the growth hormone-insulin-like growth factor axis aberrations in adult Turner's syndrome, with important modulations by treatment with 17 beta-estradiol.
    Gravholt CH; Naeraa RW; Fisker S; Christiansen JS
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2570-7. PubMed ID: 9253336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma Lp(a) and t-PA-PAI-1 complex levels in coronary heart disease.
    Süer S; Ulutin T; Sönmez H; Kökoğlu E; Uçişik N; Bayram C; Sultuybek G
    Thromb Res; 1996 Jul; 83(1):77-85. PubMed ID: 8837306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid abnormalities in Turner syndrome.
    Ross JL; Feuillan P; Long LM; Kowal K; Kushner H; Cutler GB
    J Pediatr; 1995 Feb; 126(2):242-5. PubMed ID: 7844670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of obesity on cardiovascular risk factors in Turner's syndrome.
    Elsheikh M; Conway GS
    Clin Endocrinol (Oxf); 1998 Oct; 49(4):447-50. PubMed ID: 9876341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.